Plasma PLTP (phospholipid-transfer protein): an emerging role in 'reverse lipopolysaccharide transport' and innate...

Area of Science:

• Biochemistry
• Immunology
• Molecular Biology

Background:

• Plasma phospholipid-transfer protein (PLTP) is involved in high-density lipoprotein (HDL) metabolism and reverse cholesterol transport.
• PLTP belongs to the lipid transfer/lipopolysaccharide (LPS)-binding protein (LBP) family.
• PLTP exhibits additional biological functions beyond lipid transport.

Purpose of the Study:

• To investigate the role of PLTP in the metabolism and clearance of bacterial lipopolysaccharide (LPS).
• To understand PLTP's contribution to innate immunity and inflammation.
• To examine the impact of PLTP deficiency on LPS toxicity and host survival.

Main Methods:

• Utilized PLTP-deficient mice and wild-type mice for comparative analysis.
• Studied the association kinetics of LPS with lipoproteins in vivo.
• Assessed LPS toxicity and mortality rates in response to bacterial challenge.

Main Results:

• PLTP facilitates the association of LPS with lipoproteins, a process crucial for LPS clearance.
• In PLTP-deficient mice, delayed LPS-lipoprotein association led to prolonged LPS residence time and increased aggregate toxicity.
• PLTP deficiency significantly increased mortality in mice challenged with LPS compared to wild-type controls.

Conclusions:

• PLTP plays a critical role in the innate immune response by accelerating the 'reverse LPS transport' pathway.
• PLTP modulates LPS metabolism, influencing its toxicity and the host's susceptibility to Gram-negative bacterial infections.
• Targeting PLTP activity could offer novel therapeutic strategies for managing sepsis and other inflammatory conditions.